Dashboard
Manage Tickers

RLAY


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dow-jumps-over-1-following-last-weeks-selloff-investor-sentiment-improves-but-fear--greed-index-remains-in-fear-zone
Dow Jumps Over 1% Following Last Week's Se...
09/10/2024 06:12:41

relay-therapeutics-commences-public-offering-of-200m-of-shares-of-its-common-stock
Relay Therapeutics Commences Public Offeri...
09/09/2024 20:35:16

Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%)...

crude-oil-gains-over-1-relay-therapeutics-shares-spike-higher
Crude Oil Gains Over 1%; Relay Therapeutic...
09/09/2024 18:16:34

nasdaq-surges-over-1-us-wholesale-inventories-rise-02-in-july
Nasdaq Surges Over 1%; US Wholesale Invent...
09/09/2024 16:04:18

relay-therapeutics-advances-towards-pivotal-trial-as-it-shares-encouraging-breast-cancer-data-in-heavily-pretreated-patients
Relay Therapeutics Advances Towards Pivota...
09/09/2024 15:30:00

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human...

terns-pharmaceuticals-boeing-tesla-and-other-big-stocks-moving-higher-on-monday
Terns Pharmaceuticals, Boeing, Tesla And O...
09/09/2024 14:13:07

us-stocks-higher-dow-surges-over-200-points
US Stocks Higher; Dow Surges Over 200 Points
09/09/2024 13:54:24

relay-therapeutics-reports-interim-data-for-breast-cancer-treatment
Relay Therapeutics Reports Interim Data fo...
09/09/2024 10:56:53

Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by ...

jp-morgan-maintains-overweight-on-relay-therapeutics-lowers-price-target-to-23
JP Morgan Maintains Overweight on Relay Th...
08/07/2024 18:18:47

JP Morgan analyst Eric Joseph maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and lowers the price target from ...

expert-ratings-for-relay-therapeutics
Expert Ratings For Relay Therapeutics
08/07/2024 18:00:35

oppenheimer-maintains-outperform-on-relay-therapeutics-lowers-price-target-to-24
Oppenheimer Maintains Outperform on Relay ...
08/07/2024 11:52:53

Oppenheimer analyst Matthew Biegler maintains Relay Therapeutics (NASDAQ:RLAY) with a Outperform and lowers the price target...

relay-therapeutics-q2-2024-gaap-eps-069-beats-073-estimate
Relay Therapeutics Q2 2024 GAAP EPS $(0.69...
08/06/2024 20:56:14

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(...

barclays-maintains-overweight-on-relay-therapeutics-lowers-price-target-to-14
Barclays Maintains Overweight on Relay The...
07/26/2024 11:35:44

Barclays analyst Peter Lawson maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and lowers the price target from ...

jmp-securities-maintains-market-outperform-on-relay-therapeutics-lowers-price-target-to-21
JMP Securities Maintains Market Outperform...
07/18/2024 11:27:08

JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and lowers the pr...

expert-ratings-for-relay-therapeutics
Expert Ratings For Relay Therapeutics
07/17/2024 12:01:40

hc-wainwright--co-maintains-buy-on-relay-therapeutics-lowers-price-target-to-18
HC Wainwright & Co. Maintains Buy on Relay...
07/17/2024 10:22:28

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

relay-therapeutics-receives-notice-of-termination-from-genentech-for-collaboration-and-license-agreement-relay-received-1218m-from-genentech-including-75m-upfront-and-45m-in-milestones
Relay Therapeutics Receives Notice Of Term...
07/16/2024 20:19:31

Effective In 180 Days; Agreement Involved Development Of Migoprotafib (GDC-1971); No Further Payments Or Obligations After Term...

expert-ratings-for-relay-therapeutics
Expert Ratings For Relay Therapeutics
06/07/2024 12:00:41

hc-wainwright--co-reiterates-buy-on-relay-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Rela...
06/07/2024 10:57:53

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $20 price ...

relay-therapeutics-cash-guidance-remains-unchanged-and-is-expected-to-fund-operations-into-2h-of-2026
Relay Therapeutics Cash Guidance Remains U...
06/06/2024 12:23:45

The new programs announced today do not change cash guidance, which is expected to fund operations into the second half of 2026.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION